Webb22 dec. 2024 · These studies were supported by the NIH (R03 CA215939 to MH), Cleveland Clinic (JDL), Case Comprehensive Cancer Center (JDL), and the Sontag Foundation (JDL). Address correspondence to: Justin D. Lathia or Masahiro Hitomi, Lerner Research Institute, 9500 Euclid Ave, NC10, Cleveland, Ohio 44195, USA. … WebbJustin D. Lathia, PhD Email [email protected] Phone 216.445.7475 Fax Number 216.444.9404 Professor, Department of Molecular Medicine, …
New drug target for glioblastoma -- ScienceDaily
Webb8 feb. 2024 · Cleveland Clinic Lerner Research Institute researchers believe that an aggressive population of cancer cells, ... Benjamin C. Calhoun, Jun-Lin Guan, Huiping Liu, Ofer Reizes, Justin D. Lathia. ... WebbJustin D. Lathia, PhD Email [email protected] Phone 216.445.7475 Fax Number 216.444.9404 Professor, Department of Molecular Medicine, … does theranos still exist
Justin Lathia Lab Lerner Research Institute
Webb6 apr. 2024 · Glioblastoma (GBM) is the most common malignant brain tumor with poor prognosis under the current standard treatment. It is critical to develop new approaches to selectively battle the disease. GBM sex differences suggest that an androgen receptor (AR) is a potential therapeutic target to treat AR-overexpressed GBM. Heat shock 27 … WebbExplore 15 research articles published by the author Harley I. Kornblum from University of California, Los Angeles in the year 2024. The author has contributed to research in topic(s): Stem cell & Neural stem cell. The author has an hindex of 62, co-authored 179 publication(s) receiving 14030 citation(s). Previous affiliations of Harley I. Kornblum … Webb29 juni 2024 · Justin D. Lathia Cleveland Clinic - Department of Cardiovascular and Metabolic Sciences; Cleveland Clinic - Cellular and Molecular Medicine; Cleveland Clinic - Department of Molecular Medicine; Case Western Reserve University, School of Medicine, Case Comprehensive Cancer Center Zihua Gong factories in streetsboro ohio